Olaparib Bracanat 150mg tablets

Description

Introduction Of Bracanat 150mg Tablet:

Bracanat 150mg (Olaparib) is a medication that belongs to a class of drugs called poly (ADP-ribose) polymerase (PARP) inhibitors. It is primarily used in the treatment of certain types of cancer. Bracanat 150mg (Olaparib) is available in different strengths, including the 150mg formulation.

Mechanism Of Action Of Bracanat 150mg Tablet:

The mechanism of action of Bracanat 150mg (Olaparib) involves inhibiting the activity of PARP enzymes. PARP enzymes play a role in repairing damaged DNA in cells. By inhibiting PARP, Bracanat 150mg (Olaparib) prevents the repair of damaged DNA in cancer cells, leading to their death. This mechanism is particularly effective in cancers that have deficiencies in DNA repair, such as those with mutations in the BRCA genes.

Uses Of Bracanat 150mg Tablet:

Bracanat 150mg (Olaparib) 150mg is primarily used for the treatment of advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is specifically indicated for patients who have a mutation in either the BRCA1 or BRCA2 genes and have previously received multiple lines of chemotherapy.

In addition to ovarian cancer, Bracanat 150mg (Olaparib) has also been approved for the treatment of certain types of breast cancer in patients with BRCA mutations.

Side Effects Of Bracanat 150mg Tablet:

Like any medication, Bracanat 150mg (Olaparib) can cause side effects. Common side effects associated with Bracanat 150mg (Olaparib) 150mg include:

• Fatigue
• Anemia (low red blood cell count)
• Decreased appetite
• Respiratory tract infections